Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Iveric Bio Inc (ISEE)

Iveric Bio Inc (ISEE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Iveric Bio to Present Top-line Results for Avacincaptad Pegol from Phase 3 GATHER2 Clinical Trial in Geographic Atrophy at AAO 2022 Annual Meeting

IVERIC bio, Inc. (Nasdaq: ISEE) announced today that top-line efficacy and safety results from GATHER2, the Company’s second Phase 3 clinical trial of avacincaptad pegol (ACP, also known as Zimura ®...

ISEE : 17.94 (+3.70%)
Why Iveric Bio Stock Is Skyrocketing This Week

Investors are applauding the company's late-stage clinical results for its lead pipeline candidate.

ISEE : 17.94 (+3.70%)
IVERIC bio (ISEE) Posts Positive Top-Line Data From GA Study

IVERIC bio (ISEE) reports positive top-line data from the phase III GATHER2 study, evaluating its investigational candidate, Zimura, for the treatment of geographic atrophy. Stock up.

ATRA : 3.78 (+4.13%)
ISEE : 17.94 (+3.70%)
ORIC : 3.20 (-1.23%)
ACHL : 2.26 (-7.76%)
Why Is Karuna Therapeutics, Inc. (KRTX) Up 8.4% Since Last Earnings Report?

Karuna Therapeutics, Inc. (KRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

KRTX : 224.93 (+0.19%)
ISEE : 17.94 (+3.70%)
Iveric Bio to Present at Upcoming Investor Conferences

IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Glenn P. Sblendorio, Chief Executive Officer, and Pravin U. Dugel, M.D., President, will participate in fireside chats at the following two investor...

ISEE : 17.94 (+3.70%)
Iveric Bio (NASDAQ: ISEE) Reports Positive Topline Phase 3 Trial Data for Zimura, Plans to Submit FDA New Drug Application Q1 2023

Iveric Bio, Inc. (NASDAQ: ISEE) is engaged as a biopharmaceutical company, which is focused on the research and development of

ISEE : 17.94 (+3.70%)
The 2 Stocks Everyone's Talking About Tuesday

The market looked poised to bounce after the long weekend.

COMP : 2.32 (-0.43%)
$NASX : 10,575.62 (-1.51%)
ADT : 7.49 (unch)
ISEE : 17.94 (+3.70%)
Iveric Bio Announces Positive Topline Data from Zimura® GATHER2 Phase 3 Clinical Trial in Geographic Atrophy

IVERIC bio, Inc. (Nasdaq: ISEE) today announced positive topline results from GATHER2, the Company’s second Phase 3 clinical trial of Zimura ® (avacincaptad pegol), a novel investigational complement...

ISEE : 17.94 (+3.70%)
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

IVERIC bio, Inc. (NASDAQ: ISEE) today reported that on September 1, 2022, the Company granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to two newly-hired, non-executive...

ISEE : 17.94 (+3.70%)
Iveric Bio to Participate in the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference

IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Pravin U. Dugel, M.D., President, will participate in a panel discussion titled, “Differentiation in Emerging Treatments for GA dAMD -- Perspectives...

ISEE : 17.94 (+3.70%)

Barchart Exclusives

Unusual Options Activity for United Airlines (UAL) Puts Wall Street On Notice
Although pandemic-related restrictions being lifted should help United Airlines in theory, in actuality, economic forces may end up grounding UAL stock. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar